Limited Stent Use Successful
Some patients with coronary blockage benefit from medicine-coated stents to prop the artery open. A new study confirms stents are safe with limited use.
Human Platelet Creation to be Attempted
Inherited bleeding and clotting disorders are not well understood. Scientists hope that a study to create human platelet cells, which could aid chemotherapy patients in need of platelet transfusions, will provide insight into platelet function.
FDA Approves Cardiac Drug Ticagrelor
After a lengthy regulation process, the U.S. Food and Drug Administration has approved blood-thinning drug Brilinta (ticagrelor) to treat patients with acute coronary syndromes.
FDA Approves Drug for Acute Coronary Syndromes
The U.S. Food and Drug Administration today approved the blood-thinning drug Brilinta ( ticagrelor ) to reduce cardiovascular death and heart attack in patients with acute coronary syndromes (ACS).
New Technology Reveals Coronary Artery Cells
Doctors have many different imaging technologies available to diagnose and treat patients. Viewing tiny arteries, particularly in heart patients, has proven much more difficult.
Reason for Higher Heart Risk in Blacks Found
It's long been noted that African-Americans are at an increased risk for heart attacks, but the reason remained unknown. Investigators have now discovered a potential reason for the higher heart risk.
Avoiding a Bypass
Just the thought of a bypass operation is scary for most people. But it may be that lower risk heart patients can opt for a surgery that is just as effective only not as invasive.
Better Outcomes with Coordinated Heart Care
Most of us assume if we needed a transfer to a larger hospital for heart attack treatment that it would happen quickly and efficiently. At times the transfers to open blocked arteries happen rapidly.
Cardiac Patients Not Getting Needed Drugs
Millions suffer some from some type of heart disease; from high cholesterol to more complicated heart issues. For many patients treatment is as easy as a simple daily medication.
(UPDATE 12/15) FDA Announces New Safety Recommendations For High-Dose Simvastatin
The U.S. Food and Drug Administration today is announcing safety label changes for the cholesterol-lowering medication simvastatin because the highest approved dose--80 milligram (mg)--has been associated with an elevated risk of muscle injury or myopathy , particularly during the first 12 months of use.